Vor Biopharma reported second quarter financial results in August and provided a business update which included an announcement that the company has begun construction on manufacturing facility to be added to its headquarters in Cambridge. The new manufacturing facility is designed to support clinical manufacturing for Vor’s cell therapy programs, including both eHSCs and CAR-T […]

Pfizer will acquire Cambridge-based Trillium, a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement, Pfizer will acquire all outstanding shares of Trillium for $2.26 billion, or $18.50 per share.  This represents a 118% premium to the 60-day weighted average price for Trillium. Trillium’s portfolio includes […]

The Massachusetts Biotechnology Council has released its 2021 Industry Snapshot, which shows incredible growth across the life sciences industry and also reveals forthcoming opportunities and challenges. The report found that Massachusetts-headquartered biopharma companies raised $4.3 billion in venture capital (VC) funding in the first quarter of 2021, already nearing the industry’s peak of $5.8 billion in […]

Cambridge-based startup Nuvalent has closed its upsized initial public offering of 11,212,500 shares of common stock, at a price to the public of $17.00 per share. The gross proceeds of the offering were approximately $190.6 million, before deducting underwriting discounts and commissions and other offering expenses. Nuvalent, which launched in January 2021, is creating precisely […]

Medford-based synthetic biology company GreenLight Biosciences has agreed to merge with Environmental Impact Acquisition Corp., a publicly traded special purpose acquisition company or SPAC, in a transaction that will result in GreenLight becoming a publicly-listed company. After the close of the transaction, expected in Q4 of 2021, the combined company will be listed on Nasdaq […]

As part of Sanofi’s effort to accelerate the development of therapeutics and vaccines that rely on mRNA technology, the company has announced it will acquire its mRNA partner, Lexington-based Translate Bio, for approximately $3.2 billion. “Translate Bio adds an mRNA technology platform and strong capabilities to our research, further advancing our ability to explore the promise of this technology […]

New Jersey based Tonix Pharmaceuticals has announced the start of construction for its planned 45,000 square foot clinical scale manufacturing facility in the New Bedford Business Park. The new facility is expected to house Tonix’s Advanced Development Center (ADC) for accelerated research, development, and analytical capabilities, as well as the production of clinical trial quality […]

Is the life sciences industry in Massachusetts prepared to hire and train 20,000 new employees? That’s how many jobs are expected to be added to life sciences company payrolls in Massachusetts by the end of 2024, according to the 2021 Massachusetts Life Sciences Employment Outlook published by MassBioEd, bringing total life sciences industry employment in […]

Canadian artificial intelligence therapeutics company Deep Genomics has announced the closing of a $180 million Series C financing round with SoftBank Vision Fund 2 leading the financing. Deep Genomics uses AI and machine learning to program and prioritize transformational RNA therapeutics for genetic diseases. The company plans to link its teams in Toronto with the […]

Boston biotech Albireo Pharma has won FDA approval for Bylvay (odevixibat), the first drug approved for the treatment of a rare liver disease called progressive familial intrahepatic cholestasis or PFIC. PFIC is a rare and devastating disorder affecting young children that causes progressive, life-threatening liver disease. In many cases, PFIC leads to cirrhosis and liver […]